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Abstract
Introduction: The role of systemic hemodynamics in the pathogenesis of septic acute kidney injury (AKI) has
received little attention. The purpose of this study was to investigate the association between systemic
hemodynamics and new or persistent of AKI in severe sepsis.
Methods: A retrospective study between 2006 and 2010 was performed in a surgical ICU in a teaching hospital.
AKI was defined as development (new AKI) or persistent AKI during the five days following admission based on
the Acute Kidney Injury Network (AKIN) criteria. We studied the association between the following hemodynamic targets
within 24 hours of admission and AKI: central venous pressure (CVP), cardiac output (CO), mean arterial pressure (MAP),
diastolic arterial pressure (DAP), central venous oxygen saturation (ScvO2) or mixed venous oxygen saturation (SvO2).
Results: This study included 137 ICU septic patients. Of these, 69 had new or persistent AKI. AKI patients had a higher
Simplified Acute Physiology Score (SAPS II) (57 (46 to 67) vs. 45 (33 to 52), P < 0.001) and higher mortality (38% vs. 15%,
P = 0.003) than those with no AKI or improving AKI. MAP, ScvO2 and CO were not significantly different between groups.
Patients with AKI had lower DAP and higher CVP (P = 0.0003). The CVP value was associated with the risk of developing
new or persistent AKI even after adjustment for fluid balance and positive end-expiratory pressure (PEEP) level (OR = 1.22
(1.08 to 1.39), P = 0.002). A linear relationship between CVP and the risk of new or persistent AKI was observed.
Conclusions: We observed no association between most systemic hemodynamic parameters and AKI in septic patients.
Association between elevated CVP and AKI suggests a role of venous congestion in the development of AKI. The
paradigm that targeting high CVP may reduce occurrence of AKI should probably be revised. Furthermore, DAP should
be considered as a potential important hemodynamic target for the kidney.
Introduction
Sepsis is the leading cause of acute kidney injury (AKI)
in critically ill patients [1] and is associated with high in-
hospital mortality, exceeding 50% when AKI is part of a
multiple organ failure syndrome. Among the factors pre-
disposing patients to AKI, two seem to predominate: (1)
macro- and microhemodynamic impairment [2] and (2)
immune toxicity in kidney tissue cells [3]. Although it has
been suggested for a long time, the role of compromised
systemic hemodynamics leading to AKI in septic patients
remains a source of debate [4,5]. Surprisingly, the associ-
ation between the development of AKI and systemic
hemodynamic parameters has not been extensively investi-
gated [6], particularly with regard to venous congestion.
Although studies have been done in which renal venous
congestion in heart failure [7,8] or experimental septic
AKI was suggested, renal congestion has not been ex-
plored in septic patients [9]. The present retrospective
study was designed to investigate the relation between
systemic hemodynamics and the progression of AKI in
severe sepsis or septic shock patients.
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Materials and methods
Patients
This study was approved by our local ethics committee
(Ethics Committee for the Evaluation of Biomedical Re-
search Projects of North Paris), and the need for informed
consent was waived because of the noninterventional,
retrospective design of the study. Figure 1 shows the flow-
chart of the study. All patients with a diagnosis of severe
sepsis or septic shock [10] admitted to our surgical ICU
between January 2006 and December 2010 were screened.
Patients were excluded if they did not have central venous
pressure (CVP) and/or cardiac output (CO) monitoring
(for example, cervical cellulitis) or if they died within
24 hours of admission. The selected cohort was treated ac-
cording to our local institution recommendations: antibi-
otics were administered within the 6 hours after admission
and fluid resuscitation was initiated with crystalloids
(NaCl 0.9% or Ringer’s lactate solution) or with gelatin so-
lution for some others (Plasmion; Fresenius Kabi France,
Sèvres, France). Norepinephrine was largely the most fre-
quently used vasopressor, and some patients were given a
combination of norepinephrine and either epinephrine or
dobutamine in the presence of cardiac dysfunction, a deci-
sion made by the physician in charge. When mechanical
ventilation was initiated, tidal volume was set to main-
tain an inspiratory plateau pressure less than 30 cmH2O.
Data collection
The patients’ characteristics are presented in Table 1. The
physiological parameters are presented in Table 2. The
following hemodynamic parameters were collected during
the first 24 hours after admission: CVP, CO, systolic
arterial pressure, diastolic arterial blood pressure (DAP),
mean arterial blood pressure (MAP), central venous oxy-
genation saturation (ScvO2) and mixed oxygen venous sa-
turation (SvO2). CO was measured with a pulmonary artery
catheter and a Vigilance II monitor (Edwards Lifesciences,
Irvine, CA, USA) or a transesophageal Doppler monitor
(CardioQ-ODM; Deltex Medical, Chichester, UK). Because
of hemodynamic variations during the unstable initial
phase, the lower limits and the upper limits of the range
(ULR) and the mean value over the first 24 hours were re-
corded. The association between the hemodynamic targets
within 24 hours from admission (CVP = 8 to 12 mmHg;
CO >5 L/min, MAP >65 mmHg, DAP >50 mmHg, ScvO2
>70% and SvO2 >60% [11,12]) and progression or develop-
ment of AKI was investigated. The ULR of each target was
defined as the highest value achieved at any time within the
first 24 hours after admission, and the lower limit range
was defined as the lowest value of the hemodynamic pa-
rameter during the whole 24-hour period.
Daily fluid balance was calculated as the fluid input
(volume of gelatins, crystalloids and feeding) minus fluid
output (urine output, fluid from drains and gastric aspi-
ration). Urine was collected upon admission for routine
urinary laboratory workup.
Definition
The diagnosis of AKI was based on the Acute Kidney Injury
Network (AKIN) classification. AKI upon admission was de-
fined as an increase in serum creatinine level >50% from base-
line or ≥26 μmol/L or oliguria (urinary output <0.5 ml/kg/h
Figure 1 Flowchart of patients included in the study. AKI, acute kidney injury. CO, cardiac output; CVP, central venous pressure.
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Table 1 Patient characteristicsa
Characteristics All patients (N = 137) AKI − (N = 68) AKI + (N = 69) P value
Age (years) 71.1 (56.3 to 79.8) 68.5 (49.8 to 77.5) 73.4 (60.3 to 80.7) 0.044
Males 60 (45) 35 (41.5) 42 (60.9) 0.38
Comorbidities
COPD 12 (9) 9 (13) 3 (4) 0.06
Diabetes mellitus 20 (15) 7 (10) 13 (19) 0.16
Hypertension 59 (43) 23 (34) 36 (52) 0.03
Heart failure 19 (14) 7 (10) 12 (17) 0.23
CAD 16 (12) 6 (9) 10 (14) 0.3
Liver disease 10 (7) 4 (6) 6 (9) 0.53
Cancer 39 (28) 19 (30) 20 (29) 0.89
Medication before admission
NSAIDs 7 (5) 3 (4) 4 (6) 0.71
Diuretics 28 (20) 11 (16) 17 (25) 0.22
Statins 24 (17) 9 (13) 15 (22) 0.19
Steroids 9 (7) 3 (4) 6 (9) 0.32
β-blockers 29 (2) 12 (18) 17 (25) 0.32
Antiplatelet therapy 27 (20) 13 (19) 14 (10) 0.86
Organ failure
Mechanical ventilation 118 (86) 55 (81) 63 (91) 0.08
SAPS II 50 (39 to 60) 45 (33 to 52) 57 (46 to 67) <0.0001
Norepinephrine 131 (96) 65 (95) 66 (95) 0.82
Epinephrine 17 (12) 4 (6) 13 (19) 0.02
Dobutamine 4 (3) 3 (4) 1 (1) 0.3
Dose of norepinephrineb 0.44 (0.20 to 0.73) 0.31 (0.16 to 0.54) 0.56 (0.30 to 0.95) 0.0005
Dose of epinephrineb 0.31 (0.14 to 0.40) 0.23 (0.15 to 0.32) 0.31 (0.12 to 42) 0.70
Dose of dobutamineb 5 (5 to 5) 5 (5 to 5) 5 (5 to 5) 1
Hydrocortisone 19 (14) 2 (10.5) 17 (25.4) 0.17
Lactate (mmol/L) 2.8 (1.9 to 4.8) 2.7 (1.8 to 3.9) 3 (2.1 to 6.2) 0.06
Serum creatinine (μmol/L) 141.5 (83 to 215.8) 88 (68 to 143.2) 185 (134 to 255) <0.0001
Bilirubin (mg/ml) 16 (9 to 27.8) 14 (8 to 21.8) 16 (11 to 33) 0.04
Platelet count (g/ml) 65 (30.8 to 98.2) 63 (28.8 to 89.2) 67 (31 to 102) 0.45
Hemoglobin (g/dl) 10.3 (9.4 to 12) 10.3 (9.9 to 12) 10.4 (9.3 to 12.1) 0.39
Base deficit (mmol/L) −7.7 (−11.3 to −3.4) −5 (−8.9 to −2.3) −8.8 (−13 to −5.8) 0.0006
Fluid balance (ml) 3,480 (1,945 to 5,351) 2,905 (1,350 to 4,717.5) 3,591.5 (2,597.5 to 5,714) 0.008
Origin of sepsis
Abdomen 78 (57) 37 (54) 41 (59) 0.55
Lung 28 (20) 16 (23) 12 (17) 0.37
Urinary tract 9 (7) 3 (4) 6 (9) 0.31
Soft tissue 8 (6) 5 (7) 3 (4) 0.45
Other 20 (15) 11 (16) 9 (13) 0.6
Nephrotoxic agents
Contrast media 82 (61) 41 (60) 41 (60) 0.21
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for 6 hours). Baseline serum creatinine levels were measured
in blood samples taken before hospital admission when avai-
lable (n= 37 (27%)). In cases where the baseline creatinine
level or glomerular filtration rate (GFR) was not available, the
lowest serum creatinine level measured during the patient’s
hospital stay was used if the GFR was ≥75 ml/min/1.73 m2
(n= 42 (31%)). In other cases, the baseline creatinine level
was estimated by using the Modification of Diet in Renal
Disease equation with a normal GFR value of 75 ml/min/
1.73 m2 (n = 58 (42%)) [13]. The primary endpoint was
the development of a new AKI or persistent AKI during
the 5 days following admission. New AKI was defined
as (1) an increase in serum creatinine level ≥26 μmol/L
or >50% compared to baseline value or (2) need for
renal replacement therapy (RRT) after the first 24 hours
from admission in patients who had no AKI upon ad-
mission. Persistent AKI was defined as a steady or in-
crease in AKIN classification stage between the first
24 hours following admission and day 5 in patients with
AKIN stage ≥1 at the time of inclusion in the study.
Transient AKI was defined as downstaging of AKI be-
tween the first 24 hours following admission and day 5
(for example, from AKIN stage 1 to stage 0). Patients
with no AKI or transient AKI are referred to through-
out the article as the AKI − group, and patients with
new or persistent AKI constitute the AKI + group.
Statistical analysis
Quantitative parameters are reported as median and inter-
quartile range (IQR; 25th to 75th percentile), and qualitative
parameters are expressed as number and percentage.
Categorical variables were compared using the χ2 test or
Fisher’s exact test as appropriate. Continuous variables
were compared using the Mann–Whitney U test.
Primary endpoint
The primary endpoint of the study was to evaluate the
AKI + group during the first 5 days after admission
with hemodynamic parameters recorded during the first
24 hours after admission. We performed logistic regres-
sion analysis, without and with adjustment for potential
confounding factors (fluid balance during the first day
and average positive end-expiratory pressure (PEEP) level
during the first day), to assess the association between
CVP level and risk of AKI.
Secondary endpoint
The secondary endpoint of the study was the association
of AKI with in-hospital mortality, length of stay in the
ICU or time from diagnosis of septic shock until death,
discharge or transfer. Being alive at discharge was consid-
ered a competing event with all-cause in-hospital mortality.
The association between AKI + and in-hospital mortality
was estimated using cause-specific Cox proportional
hazards models. Appropriate methods for censored data
were used. P < 0.05 was considered statistically signifi-
cant. All analyses were performed using R 2.6.2 statistical
software (The R Foundation for Statistical Computing,
Vienna, Austria).
Table 1 Patient characteristicsa (Continued)
Vancomycin 53 (39) 29 (43) 24 (35) 0.31
Aminoglycosides 9 (7) 5 (7) 4 (6) 0.71
Colloids 108 (79) 47 (69) 61 (88) 0.005
aAKI−, no or transient acute kidney injury; AKI+, new or persistent acute kidney injury; CAD, Coronary artery disease; COPD, Chronic obstructive pulmonary disease;
NSAID, Nonsteroidal anti-inflammatory drug; SAPS II, Simplified Acute Physiology Score II. bData are micrograms per kilogram per minute among patients receiving
the drug. The data in the table are expressed as median (interquartile range) or number (%).
Table 2 Hemodynamic parameters during the first
24 hours after admissiona
Parameters AKI − (N = 68) AKI + (N = 69) P value
CO (mean) 4.6 (3.6 to 6.2) 4.9 (3.8 to 6.7) 0.41
CO (LLR) 3.7 (3 to 5.4) 3.8 (2.9 to 4.8) 0.76
CO (ULR) 5.7 (3.9 to 7.1) 6 (5.1 to 8.1) 0.14
ScvO2 (mean) 74.5 (71.7 to 78.4) 74.5 (67.3 to 77.5) 0.26
SvcO2 (LLR) 71 (65 to 75) 67 (60.1 to 72.3) 0.058
SvcO2 (ULR) 80 (76 to 84.2) 80 (75.6 to 84) 0.92
SAP (mean) 110.2 (101.4 to 117) 108.5 (100.5 to 119) 0.94
SAP (LLR) 88.5 (80 to 98) 89 (77 to 100) 0.8
SAP (ULR) 128 (116 to 142) 130 (117 to 143) 0.74
DAP (mean) 54.8 (50.4 to 59.5) 51.5 (46.5 to 56) 0.028
DAP (LLR) 45 (40 to 50) 42 (37 to 46) 0.15
DAP (ULR) 64.5 (57.8 to 69.2) 60 (55 to 66) 0.022
MAP (mean) 73 (69.2 to 79.1) 72 (65.5 to 77) 0.16
MAP (LLR) 61.7 (53 to 65.5) 58 (52 to 65) 0.26
MAP (ULR) 87.5 (81 to 94) 84 (76 to 95) 0.18
CVP (mean) 8.5 (7 to 11.1) 11 (8.5 to 13) 0.00031
CVP (LLR) 4.5 (3 to 6.2) 7 (3 to 8) 0.0042
CVP (ULR) 13 (10 to 16) 15 (12 to 18) 0.00055
aAKI−, no or transient acute kidney injury; AKI+, new or persistent acute
kidney injury; CO, cardiac output; CVP, central venous pressure; DAP, diastolic
arterial blood pressure; LLR, lower limit of the range; MAP, mean arterial blood
pressure; SAP, systolic arterial blood pressure; ScvO2, central venous oxygen
saturation, ULR, upper limit of the range.
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Results
Patients’ characteristics
The study patients’ characteristics are presented in Table 1.
After screening and application of selection criteria, 137
patients were included (Figure 1). AKI was diagnosed in
105 patients (77%) upon ICU admission. From among
those patients, 69 were found to have new or persistent
AKI after admission. Respectively, 5 (16%) of 32 patients
with AKIN stage 1 AKI upon admission, 14 (46%) of 30 pa-
tients with AKIN stage 2 AKI upon admission and 35
(47%) of 47 of patients with AKIN stage 3 AKI were subse-
quently classified as AKI + (that is, persistent AKI).
Thirty-two patients required RRT, which was initiated
early (1 day (1 to 2) after ICU admission). The AKI +
group scored higher on the Simplified Acute Physiology
Score II, as well as higher base deficit and bilirubin
levels upon admission. AKI + patients had a higher posi-
tive fluid balance during the first 24 hours after admission
(3,591.5 ml/kg/h (2,597.5 to 5,714) vs. 2,905 ml/kg/h
(1350 to 4717.5); P = 0.008) and lower urinary output
(0.6 ml/kg/h (0.4 to 1.2) vs. 0.9 ml/kg/h (0.7 to 1.4);
P = 0.0045). Need for mechanical ventilation, use of vaso-
pressors and/or use of inotropes did not differ between
groups. The origin of infection and causative pathogens
did not differ between groups either (Table 1).
Relation between acute kidney injury and systemic
hemodynamics
The tested hemodynamic variables are presented in
Table 2. Only CVP level and DAP (mean and ULR) were
statistically different between patients with AKI + and
AKI−. CVP values were higher in the AKI + group (4 mmHg
(2 to 6) vs. 6 mmHg values in brackets are Interquartile
range, as specified in the Methods (statistical analysis) sec-
tion (3 to 8), respectively; P < 0.0001). In addition, CVP
was associated with new or persistent AKI (odds ratio
(OR) = 1.23 (1.10 to 1.38); P = 0.0003). In the full adjusted
model, the ORs were 1.05 (0.93 to 1.19; (P = 0.3988) for
PEEP (for 1 cmH2O) and 1.05 (1.01 to 1.09; P = 0.0154)
for positive fluid balance (for each 250 ml). The associ-
ation between CVP and new or persistent AKI remained
(OR = 1.22 (1.08 to 1.39) for an increase of 1 mmHg;
P = 0.002) after adjustment for fluid balance and PEEP
level), together with a quasi-linear relationship between
CVP level and the risk of developing new or persistent
AKI (Figure 2). The excretion fraction of sodium was
higher (1% (0.3 to 2.9) vs. 0.5% (0.2 to 0.9); P = 0.031),
and the urine/plasma creatinine ratio (38.3 (23.7 to 62.5)
vs. 65.5 (44.1 to 115.3); P = 0.001) was lower, in the AKI +
group than in the AKI − group. The excretion fraction of
urea (26.2% (13.8 to 62.5) vs. 30.1% (18 to 46.5); P = 0.21),
urinary sodium/potassium ratio (0.6 (0.4 to 1.3) vs. 0.7 (0.4
to 1.3); P = 0.77) and plasma urea/creatinine ratio (96.8
(60.9 to 119.6) vs. 100.6 (74.2 to 132.5); P = 0.19) did
not differ between groups.
Outcomes
The cohort ICU length of stay was 9 days (5 to 17). The
mortality rates were 23% (32 patients) and 26% (37
patients) in the ICU and at 28 days, respectively. The
AKI + group had a higher mortality rate in the ICU
(39% vs. 6%; P = 0.0003), in the hospital (45% vs. 16%;
P = 0.0004) and at day 28 (38% vs. 15%; P = 0.003) than
AKI − patients (Figure 3). Among the 14 survivors re-
quiring RRT, 1 was continued on it after ICU discharge.
Discussion
In the present study, we observed a weak association be-
tween systemic hemodynamic parameters and the deve-
lopment of AKI among septic ICU patients. The
hemodynamic parameter most associated with the deve-
lopment or progression of AKI, regardless of the level of
fluid balance and PEEP, was the CVP level. This suggests
participation of venous congestion in the physiopatho-
logy of AKI in severe sepsis and septic shock.
Although the role of renal hypoperfusion is believed to
contribute to the development of sepsis-induced renal
dysfunction, AKI appears to be only partially reversible
after optimization of systemic hemodynamics [14]. Re-
cently, Schnell et al. found that fluid loading did not in-
fluence the Doppler renal resistive index in septic ICU
Figure 2 Statistical model of nonparametric logistic regression
showing the relationship between mean central venous
pressure during the first 24 hours after admission and the
probability of new or persistent acute kidney injury. Note the
plateau for the incidence of acute kidney injury (AKI) when the
lower limit of central venous pressure (CVP) was between 8 and
12 mmHg. Over this limit, the rise in CVP was associated with a
sharp increase in new or persistent AKI incidence.
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patients [6]. Although resuscitation targeting the forward
determinants of renal blood flow (MAP and CO) is com-
mon, little is known about backward determinants (renal
venous pressure). In experimental studies, renal venous
congestion has been shown to be important in promot-
ing renal injury [8,15,16]. Uncoupling CO and AKI
has also been observed in experimental septic models
[17,18]. In patients with acute heart failure, the increase
in CVP, but not CO, has been found to be strongly asso-
ciated with AKI [19,20]. An association between AKI and
elevated atrial and brain natriuretic peptide levels in
chronic heart failure or after cardiac surgery suggests
that cardiac chamber distension by fluid overload and
high filling pressure is involved [21]. In the present study,
arterial pressure and CO were not statistically different be-
tween the two groups of patients, except for DAP. Because
renal vascular resistance is low, as evidenced by a positive
diastolic blood flow velocity, diastolic perfusion pressure
might be a key determinant of renal perfusion [2,6]. The re-
duction in diastolic flow may result from a decrease in dia-
stolic perfusion pressure related to an increase in renal
venous back pressure and/or a decline in DAP [22].
The intravascular level of CVP depends on the patient’s
volemic status, right and left heart function, surrounding
venous pressure increased by mechanical ventilation, and/or
reduced venous compliance. While a patient is in supine
position, the renal venous flow depends on renal venous
pressure, which is higher than CVP by at least 2 mmHg
[23]. The recommended Surviving Sepsis Campaign (SSC)
guidelines targeting CVP between “8 and 12 mmHg in spon-
taneous breathing” or “between 12 and 15 mmHg in patients
receiving mechanical ventilation” [10,12] might correspond
to a level of renal venous pressure as high as 17 mmHg. To
illustrate such a concept, the computed average renal
diastolic perfusion pressure was estimated to be approxi-
mately 35 mmHg in the AKI + group vs. about 42 mmHg in
the AKI− group, a difference that may affect glomerular fil-
tration pressure.
Fluid resuscitation and pressure optimization to better
perfuse the kidney, a landmark treatment for septic patients,
is based on the improvement of renal perfusion pressure.
For some patients, the induced CVP elevation may over-
come the DAP increase, reducing renal perfusion with
harmful effects on renal function. This aspect is supported
by the recently reported association between fluid overload
and mortality in critically ill patients, especially in patients
with AKI or septic shock [24], and confirmed by post hoc
analysis of the Vasopressin and Septic Shock Trial [25]. The
investigators in that trial reported that a positive fluid ba-
lance and elevated CVP were associated with increased
mortality in patients with septic shock [25]. Other factors
may also accompany the venous congestion mechanism,
such as an increase in renal interstitial pressure associated
with hyperpermeability and inflammatory cell adherence
[26-28]. The creation of a vicious circle with oliguria and
fluid-loading may then aggravate AKI. Therefore, achieving
a defined CVP as a therapeutic target might not be suitable
in septic patients. Our study suggests instead that
hemodynamic targets are best achieved at low CVP (that is,
CVP less than 8 to 12 mmHg). The SSC guidelines mention
that “in mechanically ventilated patients or those with known
preexisting decreased ventricular compliance, a higher target
CVP of 12–15 mmHg should be achieved to account for the
impediment in filling” [12]. The vast majority (86%) of our
patients were under mechanical ventilation during the first
24 hours after ICU admission and would therefore be ex-
pected to achieve higher CVP. The results of our study sug-
gest, however, that such targets might be too high from a
renal perspective. The strategy to be applied in patients pre-
senting with high CVP or with elevation of CVP during re-
suscitation requires additional studies, but fluid restriction in
these patients is an important option to be considered.
Our study has several limitations. First, the sample
size was rather small, thus our results must be con-
firmed in a larger, multicenter cohort. Only patients with
hemodynamic monitoring, including CVP, were included,
which may have introduced bias. In this respect, we se-
lected patients with the most severe forms of sepsis, as de-
fined by the high Sequential Organ Failure Assessment
scores, with the large majority of them being under me-
chanical ventilation and treated with vasopressors. Also, a
high proportion (32%) of patients received RRT, which
appears to be consistent with a recently published obser-
vational cohort of patients with septic shock [29].
Second, the study design was noninterventional, and
the association between CVP and AKI does not prove
a causal relationship. Whether actively decreasing CVP
may improve outcomes and prevent AKI needs further
Figure 3 Survival according to the occurrence of new or persistent
acute kidney injury in survival according to the occurrence of AKI.
AKI, acute kidney injury.
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evaluation, and which strategy should be applied to
patients with high CVP merits further study.
Conclusions
In this study, we observed a loose association between
most systemic hemodynamic parameters and development
of new or persistent AKI in septic patients, with the excep-
tion of CVP. The association of the level of CVP and the
risk of developing AKI suggests a role of venous conges-
tion in the development of AKI. The paradigm targeting
high CVP to reduce occurrence of AKI should be reconsi-
dered in this setting.
Key messages
 AKI progresses in about 50% of septic patients
despite hemodynamic optimization.
 We observed a weak association between systemic
hemodynamic parameters and AKI in septic patients.
 Higher mean CVP in the first 24 hours was linearly
associated with increasing risk of new or persistent
AKI across all observed CVP values.
 The association of elevated CVP with AKI suggests a
role of venous congestion in the development of AKI.
 The paradigm that targeting high CVP may reduce
the occurrence of AKI should be revised.
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